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Abstract
Purpose—To determine the ability of frequency doubling technology (FDT) and scanning laser 
polarimetry with variable corneal compensation (GDx-VCC) to detect glaucoma when used 
individually and in combination.
Methods—One hundred and ten normal and 114 glaucomatous subjects were tested with FDT 
C-20-5 screening protocol and the GDx-VCC. The discriminating ability was tested for each 
device individually and for both devices combined using GDx-NFI, GDx-TSNIT, number of 
missed points of FDT, and normal or abnormal FDT. Measures of discrimination included 
sensitivity, specificity, area under the curve (AUC), Akaike’s information criterion (AIC), and 
prediction confidence interval lengths (PIL).
Results—For detecting glaucoma regardless of severity, the multivariable model resulting from 
the combination of GDX-TSNIT, number of abnormal points on FDT (NAP-FDT), and the 
interaction GDx-TSNIT * NAP-FDT (AIC: 88.28, AUC: 0.959, sensitivity: 94.6%, specificity: 
89.5%) outperformed the best single variable model provided by GDx-NFI (AIC: 120.88, AUC: 
0.914, sensitivity: 87.8%, specificity: 84.2%). The multivariable model combining GDx-TSNIT, 
NAPFDT, and interaction GDx-TSNIT*NAP-FDT consistently provided better discriminating 
abilities for detecting early, moderate and severe glaucoma than the best single variable models.
Conclusions—The multivariable model including GDx-TSNIT, NAP-FDT, and the interaction 
GDX-TSNIT * NAP-FDT provides the best glaucoma prediction compared to all other 
multivariable and univariable models. Combining the FDT C-20-5 screening protocol and GDx-
VCC improves glaucoma detection compared to using GDx or FDT alone.
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Glaucoma is an ocular disease of public health concern due to its high prevalence and 
significant morbidity worldwide. Because early treatment is effective in delaying the onset 
of glaucoma1 or the progression of glaucomatous damage,2 it is critical from a public health 
perspective to develop simple, quickly administered, easily interpreted, sensitive and 
specific methods to identify individuals with glaucoma. Also, finding methods that use non-
physicians in the screening setting would represents a better use of limited resources. 
Frequently used methods in these groups of individuals include measurement of intraocular 
pressure (IOP) and ophthalmoscopy estimation of cup-to-disc ratio (CDR). However, these 
methods have low sensitivity and specificity in distinguishing normal eyes from those with 
glaucoma.3, 4 Standard automated perimetry (SAP), another important glaucoma diagnostic 
test, is difficult to use in population screening due to its non-portability, long testing time, 
fatigue-related artifacts, and subject’s response variability. In recent years, other 
technologies have been developed to detect glaucomatous visual field (VF) loss5 and 
damage to the retinal nerve fiber layer (RNFL).6
Given that glaucomatous damage affects both optic nerve structure and function, it is 
advantageous to consider both aspects for glaucoma diagnosis. Indeed, it has been shown 
that combining structure and function tests improves the diagnostic detection compared to 
either test used individually.7 With regard to frequency doubling technology (FDT) and 
scanning laser polarimetry (SLP), two earlier studies screened for glaucoma after combining 
these two instruments. One of them found that combining these two instruments improves 
the sensitivity to detect glaucoma as compared to using either instrument individually,8 
whereas the other did not find any improvement in diagnostic performance after combining 
the two instruments.9 However, both of these studies used SLP with fixed corneal 
compensation (FCC), which had the drawback of sometimes providing erroneous 
measurements inherent to incomplete compensation of corneal birefringence. The variable 
corneal compensation (VCC) feature later added to upgrade the GDx allows good 
visualization of the RNFL10 and better differentiation between healthy and glaucomatous 
eyes compared to GDx-FCC.11, 12 On the other hand, studies have reported that FDT testing 
results strongly correlate with those of conventional Humphrey Visual Field (HVF)13, 14 and 
that FDT may detect glaucomatous functional loss earlier than SAP.15 One concern about 
FDT as a screening tool has been its high false positive rate,16 which has led to the 
recommendation that FDT should not be used alone as a screening test for glaucoma.17 The 
aim of the present study was to evaluate the performance of FDT and GDx-VCC in 
detecting glaucoma when used individually and in combination.
METHODS
Subjects
One randomly selected eye from each of 110 normal and 114 glaucomatous subjects was 
included in this study. Written informed and Health Insurance Portability and Accountability 
Act consents were obtained from all participants after the study was approved by the Human 
Subject Research Office Committee of the Miami Miller School of Medicine. All 
participants were recruited among outpatients attending comprehensive ophthalmology, 
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optometry and glaucoma clinics of the Anne Bates Leach Eye Hospital, Bascom Palmer Eye 
Institute, Miller School of Medicine, University of Miami. All subjects underwent an 
eligibility screening eye examination. The examination included measurement of visual 
acuity and IOP, slit-lamp examination and fundus ophthalmoscopy and a review of previous 
HVF (Carl Zeiss Meditec Inc, Dublin, California) tests. Subjects were classified as normal if 
they had best-corrected visual acuity ≥ 20/40; IOP ≤ 21 mm Hg; normal fundus examination 
with cup-to-disc ratio (CDR) up to 0.6, but without evidence of optic nerve or macular 
disease, or interocular asymmetry in CDR ≥ 0.2, focal thinning of the optic disc rim, optic 
disc drusen, pallor or hemorrhage, age-related macular degeneration, or diabetic retinopathy. 
Subjects with glaucoma were included if they had a diagnosis of glaucoma as confirmed by 
a glaucoma specialist based on glaucomatous optic nerve head (ONH) changes with 
accompanying glaucomatous VF loss in at least one eye. At least two reliable SITA standard 
24-2 HVF tests were required, with the most recent of them performed within one year of 
the enrollment date. VF defects were considered glaucomatous if they met the minimum 
criteria for a field defect: the Glaucoma Hemifield Test (GHT) was outside normal limits, 
the pattern standard deviation had P values < 5%, or if there was a cluster of 3 or more 
points in the pattern deviation plot in a single hemifield (superior or inferior) with P values 
< 5%, one of which must have a P value < 1%. The severity of glaucoma was defined based 
on the Hodapp-Parrish-Anderson VF severity grading scale.18 Exclusion criteria for both 
normal and glaucomatous subjects included age < 18 years, best corrected VA worse than 
20/40 in both eyes, a history of retinal disease (macular degeneration, diabetic retinopathy) 
or optic nerve disease (non-glaucomatous optic neuropathy).
Frequency Doubling Technology Perimetry
FDT is a portable lightweight instrument resistant to refractive blur up to 6 diopters, thus not 
requiring correction of refractive errors.19 Testing was therefore completed with the 
subject’s habitual correction. All participants were instructed on how to complete the FDT 
test using an instruction card and through simulated testing in demonstration mode. All 
selected eyes were evaluated with the FDT perimeter (software version 4.00.0, Welch Allyn, 
Humphrey Systems, Carl Zeiss Meditec Inc., Dublin, California) with undilated pupils using 
the C-20-5 screening protocol. Details about the functioning and data acquisition have been 
extensively presented in the review by Anderson and Johnson.20 If the first testing of an eye 
showed one or more abnormal points, a second confirmatory test was performed in that eye. 
To be considered abnormal, one or more locations had to be identified at least at P < 5% at 
the same location on a second test. The FDT was considered reliable if false positives, false 
negatives, and fixation losses were all less than 33%. Patients with at least one reliability 
parameter exceeding 33% were excluded. Unreliable tests consisting of fixation losses 
and/or false positives were not considered for data analysis.
Scanning Laser Polarimetry
All eyes were imaged with the GDx-VCC (software version 5.5.1, Carl Zeiss Inc., Dublin, 
California). The spherical equivalent of the refractive error of each eye was entered into the 
instrument prior to scanning. All participants were familiarized with the testing procedures 
prior to actual testing. Testing was performed with pupils undilated. Only good quality scans 
(quality score ≥ 7, evenly illuminated images with perfectly centered optic disc, without 
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motion artifacts, and no atypical birefringence pattern of RNFL thickness pattern in the four 
quadrants) were retained for analysis. From all GDx-VCC output measures provided, only 
the nerve fiber indicator (NFI) and the Temporal-Superior-Nasal-Inferior-Temporal 
(TSNIT) were considered for statistical analysis in the present study. The NFI is a computer-
driven vector based on an advanced neural network algorithm and trained to differentiate 
normal from glaucomatous eyes. Potential NFI scores range from 0 to 100. The TSNIT 
average is a summary measure based on RNFL thickness values within the calculation circle 
around the ONH. It is automatically compared to the normative database and is quantified in 
terms of probability of normality. Normal values are displayed in green, abnormal values are 
color-coded based on their probability of normality so that dark blue indicates a 5% 
likelihood of being normal, light blue indicates the 2% level, yellow 1%, and red 0.5%. 
Patients with poor quality images (poorly or unevenly illuminated reflectance, quality score 
< 7, or atypical retardation pattern were excluded). Scans with normal or atypical retardation 
pattern were identified by visual inspection. Images with normal retardation pattern were 
defined as those with retardation maps with highest retardation superiorly and inferiorly 
indicating thicker RNFL and low retardation nasally and temporally indicating thinner 
RNFL. Images with abnormal retardation pattern were defined as those having alternating 
areas of low and high retardation arranged in a spoke-like manner in the peripapillary area, 
or those with high retardation in the nasal and temporal sectors.
Statistical Analysis
The study sample population was divided into two thirds for modeling and one thirds for 
validation. This was done to account for the over-fitting principle in modeling in which 
evaluating an index with the same sample used to create it may result in overestimation of 
that index efficacy. This was achieved by stratification so that all four groups (normal, mild, 
moderate, and severe glaucoma subjects) were balanced in both the modeling and validation 
sets. This procedure yielded 150 cases (76 normal, 33 early glaucoma, 24 moderate 
glaucoma, and 17 severe glaucoma) with which to build a discrimination model. Univariable 
and multivariable prediction models were generated using simple and backward selection 
logistic regression, respectively, with glaucoma status as the outcome variable and NFI, 
TSNIT, number of abnormal points on FDT (NAP-FDT), and normal or abnormal FDT as 
candidate variables. A linear predictor score was created from the logistic regression 
coefficients and then submitted to a receiver operating characteristic (ROC) curve analysis, 
after which linear predictor scores were calculated for the cases in the validation set 
comprising 34 normal subjects and 40 patients with glaucoma (22 early, 8 moderate, 10 
severe). The logistic regression models provide predicted probabilities of glaucoma status 
based on the estimated model parameters. The prediction formula for an individual is given 
as
Where χ1 and χ2 are the individual’s GDx-TSNIT and NAP-FDT measurements, 
respectively, χ1χ2 is the product of the two measurements (interaction), and β0, β1 and β2 are 
the logistic regression model parameters which are unknown but estimated using the data. 
Mwanza et al. Page 4













Akaike’s information criterion (AIC), area under the curve (AUC) of the ROC, sensitivity, 
and specificity were determined for both univariable and multivariable models. In addition, 
the proportion of correctly classified subjects and the median prediction interval length 
(PIL) were determined in the validation set. All statistical analyses were performed with 
SAS version 9.2 (SAS, Cary, NC, USA). A P value ≤ 0.05 was considered statistically 
significant.
RESULTS
Demographic and Clinical Characteristics of Participants
A total of 124 normal and 155 glaucomatous eyes were initially enrolled in the study. After 
excluding 14 normal eyes (1 for unreliable FDT, 4 for GDx with low quality score, 9 for 
abnormal retardation pattern on GDx) and 41 glaucomatous eyes (21 for unreliable FDTs, 5 
for GDX scans with quality score, 15 for GDx scans with abnormal retardation pattern), 110 
normal and 114 glaucomatous eyes (55 mild, 32 moderate, and 27 severe) were available for 
analysis. The right eye was selected as study eye 55.4% of the time (124/224), and the left 
eye 44.6% of the time (100/224). Females represented 61.2% (137/224) of subjects. 
Unpaired Student t-test comparisons revealed that normal and glaucomatous eyes differed 
significantly with regard to age (58.0 ± 10.7 years vs. 69.1 ± 12.2 years), CDR (0.3 ± 0.1 vs. 
0.7 ± 0.2), GDx NFI (20.7 ± 9.7 vs. 54.0 ± 24.6), GDx-TSNIT (52.1 ± 5.5 μm vs. 40.2 ± 8.2 
μm), and the NAP-FDT (1 ± 3 vs. 8 ± 5) (all P < 0.001, unpaired Student t-test, means and 
standard deviations presented), but not GDx scan quality score (8.6 ± 0.7 vs. 8.4 ± 0.9, P = 
0.06). Analysis of variance showed that eyes with mild glaucoma significantly differed from 
those with moderate and severe glaucoma in CDR (P = 0.023 and 0.008), GDx-NFI (both P 
< 0.001), GDx-TSNIT (both P < 0.001), and NAP-FDT (both P < 0.001). The comparison 
between moderately and severely affected eyes did not reach significance levels in any of 
the parameters (P = 0.17 - 0.88). As a sensitivity analysis, we refit each of the statistical 
models while controlling for age as a continuous variable.
Glaucoma Detection Using Single and Combined Devices
The results of both the univariable and multivariable models are shown in Table 1 and Table 
2. Controlling for age did not affect the outcomes of the analyses as the age-adjusted and 
unadjusted results differed only slightly. As a result, we choose to present the unadjusted 
results. For diagnosing glaucoma using a single instrument, GDx-NFI provided the best 
single variable model for discriminating normal subjects and subjects with glaucoma 
regardless of severity (AIC: 120.88, AUC: 0.914, sensitivity: 87.8%, specificity: 84.2%), 
early glaucoma (AIC: 102.26, AUC: 0.872, sensitivity: 87.9%, specificity: 80.3%), and 
moderate glaucoma (AIC: 44.16, AUC: 0.961, sensitivity: 95.8%, specificity: 92.1%). NAP-
FDT was the best model for severe glaucoma (AIC: 36.48, AUC: 0.976, sensitivity: 94.1%, 
specificity: 97.4%). The backward selection multivariable fitting procedure consistently 
identified the combination GDx-TSNIT, NAP-FDT, and the interaction GDx-TSNIT * 
NAP-FDT as the best discriminating model between normal controls and glaucoma patients 
regardless of severity (AIC: 88.28, AUC: 0.959, sensitivity: 94.6%, specificity: 89.5%) and 
between normal subjects and subjects with mild (AIC: 76.06, AUC: 0.930, sensitivity: 
87.9%, specificity: 89.5%), moderate (AIC: 39.37; AUC: 0.983, sensitivity: 100%, 
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specificity: 88.2%), and severe glaucoma (AIC: 30.62, AUC: 0.986, sensitivity: 100%, 
specificity: 92.1%). This multivariable model combining GDx and FDT parameters always 
outperformed the best single variable models (Table 1, Table2, and Figure). To determine 
whether multivariable models including GDx-NFI were better than the model based on 
GDx-TSNIT, both stepwise and forward selection logistic regression analyses were 
performed. The performance of the model combining GDx-TSNIT, NAP-FDT, and 
interaction GDx-TSNIT * NAP-FDT was consistently slightly better than the combination 
GDx-NFI, NAP-FDT, and interaction GDx-NFI * NAP-FDT (AIC: 90.79 for glaucoma 
regardless of severity and 79.63 for early glaucoma) and the combination GDx-NFI and 
NAP-FDT (AIC: 40.25 for moderate glaucoma and 32.53 for severe glaucoma).
Table 3 displays the estimates for the glaucoma regardless of severity, early, moderate, and 
severe glaucoma models. Along with a predicted probability of glaucoma, the logistic 
regression model also provides a 95% confidence interval for the prediction (prediction 
interval). We prefer models with shorter prediction intervals since models that produce large 
intervals indicate that there is a large amount of uncertainty associated with the predictions.
DISCUSSION
The issue of implementing population screening has constantly been hampered by 
controversy over cost effectiveness and the lack of an ideal screening test.21, 22 Since the 
approach based on detecting early cases is costly and time-consuming for population-based 
screening, a different approach would be to target only people with moderate to advanced 
glaucoma. This would be advantageous in terms of reducing the burden of false positive 
cases that might potentially overwhelm the healthcare system. The use of FDT and GDx in 
this study conforms with the philosophy of the World Glaucoma Association,23 according to 
which an ideal screening test for OAG should be safe, easy to administer and interpret, 
portable, quick, acceptable to the people who are tested, able to obtain results in the majority 
of tested individuals and sufficiently valid to distinguish between those who do and those 
who do not have OAG. Both FDT and GDx-VCC fulfill these criteria and may be good 
candidates for population screening of glaucoma.
The concept of combining structural and functional tests to diagnose glaucoma and monitor 
its progression is based on the fact that glaucoma is characterized by structural and 
functional damage. The usefulness of this approach has been the subject of several 
studies.7-9, 24-27 Only a very limited number of studies have assessed the diagnostic 
capability of combined GDx-VCC and FDT.8, 9 Methodologically, the uniqueness of the 
present study lies in 1) the use of a modeling set and a validation set (known to be a more 
objective way of measuring the performance of various models that have been fit to the 
training set), 2) the use of the absolute values of NFI and TSNIT and the NAP-FDT as 
candidate variables in the multivariable analysis, and 3) the use of AIC and PIL as 
diagnostic performance measures for the first time, in addition to sensitivity, specificity, and 
AUC.
The results of our study show that the multivariable model combining GDx-TSNIT, 
NAPFDT, and the interaction GDX-TSNIT * NAP-FDT consistently outperformed the best 
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single variable models of either GDx or FDT alone for discriminating normal and glaucoma 
status regardless of glaucoma severity or normal and any stage of the disease. Heeg et al.9 
compared the performance of FDT total deviation probability plot of the full mode when 
used alone and in combination with GDx-NFI with a cutoff point >29 in 237 normal and 452 
glaucomatous individuals. This combination resulted in a sensitivity decrease from 90% to 
83% and a specificity gain from 86% to 94%. The combined sensitivity increased to 99% 
after excluding patients with early glaucoma. In the study by Horn and colleagues,8 FDT 
screening protocol (C-20-5) and GDx-NFI used individually in 252 patients had sensitivities 
of 85% and 64%, respectively, at a predefined specificity of 95%. When the two devices 
were combined, the sensitivity increased to 92%. In pre-perimetric glaucoma, FDT and GDx 
had the same sensitivity of 25%, which significantly increased to 44% after combination of 
the two tests. Similarly, Shah et al.7 observed a significant increase (from 42% to 63%) in 
GDx-NFI sensitivity with negligible decrease in specificity (from 98% to 97%) following 
combination with FDT-PSD from N-30 thresholding protocol. Toth et al.27 performed 
glaucoma screening using GDx-VCC and Matrix FDT (MFDT). Used individually, GDx 
NFI showed a low sensitivity of 26%, a specificity of 97%, and an AUC of 0.89. Combining 
abnormal NFI with MFDT screening mode (>2 points with P < 0.05) further significantly 
decreased the sensitivity to 12% with corresponding specificity of 100% and AUC of 0.91. 
Alternatively, a combination of MFDT (1 point with P < 5%), NFI, and nerve fiber bundle 
defect on the GDx-VCC deviation map, with at least two of these parameters being 
abnormal, only increased the sensitivity to 42%. Although there are discrepancies in 
diagnostic performance measures that may mostly be ascribed to differences in methodology 
(i.e. NFI cutoffs, FDT protocol) and study participants (i.e. sample size, disease severity 
studied), there is a general agreement that combining FDT and GDx-VCC improves the 
glaucoma diagnostic performance of either device used individually.
We also compared the performance of the multivariable model to that of CDR as estimated 
by ophthalmoscopy (Tables 1 and 2) based on the fact that CDR is not a good metric for 
detecting glaucoma, particularly in early stages. Based on the AIC analysis, it is clear that 
the multivariable model outperforms the CDR model for “All Cases”, “Moderate Cases”, 
and “Severe Cases”. For “Early Cases”, the AIC values are more similar though the 
multivariable model value is still lower. Interestingly, the AUC values are always higher for 
the multivariable model as well. Although the confidence intervals overlap, the estimated 
sensitivities at fixed levels of specificity are also larger in each case for the multivariable 
model.
The interactive effect of GDx-TSNIT and FDT-NAP reported herein set this study apart 
from prior studies. From the practical standpoint, this finding signifies for example that that 
while a moderately low GDx-TSNIT and moderately high FDT-NAP may individually have 
glaucoma diagnostic value, beyond these simple effects, the multiplicative GDX-TSNIT * 
NAP-FDT effect of both increases the probability of glaucoma. It is important to note that 
clinicians often look for interaction between variables mentally when deciding if glaucoma 
is present, and give “extra value” when multiple streams of data tend to suggest the presence 
of glaucoma. Thus, this interaction is clinically relevant because it increases the 
interpretability of test results.
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Akaike’s information criterion (AIC) is an indicator of the goodness of fit of a proposed 
model. It balances model fit with complexity by penalizing models with an increased 
number of parameters, discouraging overfitting. Models with lower AIC values are preferred 
with differences of four or more typically taken to be meaningful. AIC values can only be 
compared across models fit to the same dataset and do not indicate that any of the proposed 
models are necessarily adequate, as only comparisons between the models are relevant. Use 
of AIC is commonly used to determine the preferred model among a set of candidate 
models.28 The PIL is another useful measure in comparing the predictive ability of 
competing models and should not be used without also considering the other measures (AIC, 
AUC, sensitivity, specificity). A predictive model that is estimating probabilities near 0.5 
will likely have a larger confidence interval associated with the estimate than a model that is 
estimating probabilities closer to 0 or 1. Models that are able to clearly distinguish between 
people with and without glaucoma are preferable. A prediction near 0.5 is clearly not as 
informative as a prediction closer to 0 or to 1. The PIL is able to penalize these models that 
are unable to clearly differentiate these people. If a model is providing predicted 
probabilities near 0 or 1 and these values are incorrect, this will be reflected in the other 
measures such as AIC, AUC, sensitivity, and specificity. Also, for two models that produce 
similar predicted probabilities, the PIL lets us know which model is predicting the 
probabilities with less uncertainty. We would then prefer the model with the smallest PIL, 
since both predictions are essentially equal. For these reasons, we suggest using PIL as a 
tool in conjunction with the other measures.
Because detecting glaucoma at an early stage is critical to delay the progression of structural 
and functional damage, a good diagnostic test should be highly sensitive and specific not 
only for moderate to severe, but for early disease as well. Logically, a combined structure-
function approach would be more indicated for the detection of early glaucoma, for which 
establishing a reference standard remains difficult, since in some people, optic disc damage 
precedes VF, whereas in others it is the other way around.1 While the search for an ideal 
method combining structural and functional tests for glaucoma population screening 
continues, our results suggest that the combination proposed here may be particularly useful 
for detecting moderate to severe glaucoma. Interestingly, the results also show that the 
model proposed herein is also suitable for detection of all stages of glaucoma. As noted in 
Table 1, the optimal specificities are located around 90% for each multivariable model and 
each type of glaucoma (all: 89.5%, early: 89.5%, moderate: 88.2%, severe: 92.1%). The 
associated sensitivities are also shown to be high in comparison with the other models as 3 
out of the 4 are at least 94.6% and two of those are 100%. This suggests that at the optimal 
performance level of the multivariable models, the specificity and sensitivities are 
reasonably high. This represents an improvement over the optimal performance of the single 
variable models which often have optimal specificities much lower than 90% or in the case 
when specificity is high, very low sensitivities. Thus, the multivariable models balance the 
need for high sensitivity and specificity and represent an improvement over the single 
variable models in this regard.
This study has some limitations. First, it is a hospital-based study that was performed in a 
case-control manner, with the diagnosis of glaucoma based on typical glaucomatous ONH 
changes and supporting characteristic VF defects whereas normal subjects were required to 
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have normal IOP, normal looking ONH, and normal VF. Also, normal subjects were 
younger than subjects with glaucoma, and would be less likely to have lens opacities that 
might create non-glaucomatous FDT defects. Therefore, the results herein presented cannot 
directly be extrapolated to the general population; however, they provide valuable 
information of what to expect when combining the results of FDT and GDx-VCC TSNIT. 
These two instruments are portable, have short testing time, are easy for the patient to 
understand, are easy to administer and interpret by a non-physician operator, and do not 
require pupil dilation. These characteristics, which are not specific to these two devices, 
make their concurrent use one of the alternatives among possible combinations of laucoma 
diagnostic devices. Second, we did not use the GDx-VCC typical scan score (TSS) as a 
quantitative measure of discriminating between scans with normal and abnormal retardation 
pattern.29, 30 The TSS ranges from 0 (atypical retardation) to 100 (very typical retardation) 
and is derived from a support vector machine. Since glaucoma patients with abnormal 
retardation pattern are likely to be wrongly classified as false negative, abnormal retardation 
in glaucoma patients decreases the accuracy of the NFI as a result of the decrease of typical 
scan score (TSS) accuracy. The fact that the NFI had good AUCs in our study may 
indirectly indicate that TSSs were also high, particularly in the typical to very typical range. 
Third, although GDx provides more than 10 parameters, the NFI has been consistently 
shown to yield the best glaucoma diagnostic performance. The TSNIT average has also been 
shown to perform better than most of the other parameters, such as temporal and nasal 
averages, superior and inferior ratios, maximum modulation, superior and inferior 
maximum, ellipse modulation, temporal to nasal and inferior to nasal ratios, total, superior 
and inferior integrals. For these reasons, we chose to include only the NFI and TSNIT 
average in the assessment. Whether including the other GDx parameters would have yielded 
better performances than reported in the manuscript is doubtful. Interestingly, our model 
with these two parameters generated encouraging results. Fourth, we also acknowledge that 
the GDx-VCC has been outdated by the GDx-ECC. The GDx-VCC may exhibit an atypical 
retardation pattern that sometimes makes interpretation of the results difficult, as a result of 
poor signal-to-noise ratio. In contrast, the GDx-ECC is an improvement relative to the VCC 
version, with improved signal-to-noise ratio and introduction of a large birefringence bias 
that shifts the measurement of total retardation into a higher value region, ultimately 
resulting in better polarimetric image analysis, sensitivity, and specificity. However, it is 
important to bear in mind that for the advent of the GDx-ECC did not take away the good 
diagnostic value of the GDXVCC.
In conclusion, combining FDT C-20-5 protocol and GDx-VCC improves glaucoma 
detection in comparison with GDX or FDT used alone. The combination of GDx-TSNIT, 
NAP-FDT, and their interaction provides the best glaucoma discriminating model.
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Receiver operating characteristic (ROC) curves of FDT and GDx-VCC used individually 
and in combination for detection glaucoma regardless of severity (top left), early glaucoma 
(top right), moderate glaucoma (bottom left), and severe glaucoma (bottom right).
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Table 1
Glaucoma Status Prediction with Univariable and Multivariable Models of GDx and FDT
Glaucoma group Model AIC AUC Sensitivity Specificity CC* PIL*
All NFI** 120.88 0.914 87.8 84.2 86.5 0.180
TSNIT 126.58 0.902 79.7 93.4 82.4 0.189
NAP-FDT 129.12 0.881 83.8 86.8 78.4 0.165
FDT 129.00 0.853 83.8 86.8 78.4 0.163
CDR 102.90 0.931 93.2 81.6 85.1 0.137
Multivariable 88.28 0.959 94.6 89.5 83.8 0.147
Early NFI** 102.26 0.872 87.9 80.3 80.4 0.178
TSNIT 101.40 0.854 72.7 86.8 76.8 0.199
NAP-FDT 109.98 0.796 69.7 86.8 71.4 0.162
FDT 103.67 0.783 69.7 86.8 71.4 0.155
CDR 79.32 0.908 87.9 81.6 80.4 0.186
Multivariable 76.06 0.930 87.9 89.5 82.1 0.240
Moderate NFI** 44.16 0.961 95.8 92.1 95.2 0.105
TSNIT 49.49 0.946 91.7 94.7 92.9 0.124
NAP-FDT 55.56 0.929 91.7 92.1 81.0 0.104
FDT 61.80 0.893 91.7 86.8 71.4 0.155
CDR 50.99 0.936 91.7 90.8 92.9 0.112
Multivariable 39.37 0.983 100 88.2 83.3 0.125
Severe NFI 39.14 0.931 88.2 94.7 100 0.106
TSNIT 44.12 0.932 94.1 93.4 93.2 0.134
NAP-FDT** 36.48 0.976 94.1 97.4 88.6 0.079
FDT 38.07 0.934 100 86.8 77.3 0.110
CDR 37.13 0.968 100 81.6 84.1 0.122
Multivariable 30.62 0.986 100 92.1 88.6 0.121
AIC, Akaike’s information criterion; AUC, area under the curve; CC, proportion subjects correctly classified; PIL, median prediction interval 
length; NFI, nerve fiber indicator; TSNIT, average RNFL; NAP-FDT, number of abnormal points on FDT; FDT, normal or abnormal; CDR, cup-
to-disc ratio.
*
Calculated using the validation set;
**
Best single variable model
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Table 2




(90% Spec.) 95% CI
Sensitivity
(95% Spec.) 95% CI
All NFI 78.4 (60.4, 89.6) 71.6 (49.7, 86.6)
TSNIT 79.7 (62.0, 90.4) 71.6 (49.7, 86.6)
NAP-FDT 82.4 (65.4, 92.1) 60.8 (38.8, 79.2)
FDT -- -- -- --
CDR 83.8 (67.1, 92.9) 66.2 (44.0, 83.0)
Multivariable 89.2 (74.4, 95.9) 73.0 (51.1, 87.4)
Early NFI 60.6 (37.7, 79.6) 51.5 (27.7, 74.7)
TSNIT 63.6 (40.5, 81.8) 54.5 (30.1, 76.9)
NAP-FDT 60.6 (37.7, 79.6) 33.3 (14.7, 59.1)
FDT -- -- -- --
CDR 75.8 (52.7, 89.8) 48.5 (25.3, 72.3)
Multivariable 81.8 (59.6, 93.2) 60.6 (35.3, 81.3)
Moderate NFI 95.8 (72.3, 99.5) 87.5 (60.9, 96.9)
TSNIT 91.7 (68.1, 98.3) 87.5 (60.9, 96.9)
NAP-FDT 91.7 (68.1, 98.3) 79.2 (51.2, 93.2)
FDT -- -- -- --
CDR 91.7 (68.1, 98.3) 83.3 (55.9, 95.2)
Multivariable 95.8 (72.3, 99.5) 91.7 (66.0, 98.4)
Severe NFI 88.2 (59.1, 97.5) 88.2 (57.1, 97.7)
TSNIT 94.1 (64.4, 99.3) 82.4 (50.8, 95.5)
NAP-FDT 100 -- 94.1 (62.6, 99.4)
FDT -- -- -- --
CDR 88.2 (59.1, 97.5) 76.5 (44.9, 92.8)
Multivariable 100 -- 94.1 (62.6, 99.4)
AUC, area under the curve; NFI. nerve fiber indicator; TSNIT. average RNFL; NAP-FDT, number of abnormal points on FDT; FDT, normal or 
abnormal; CDR, cup-to-disc ratio.
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Table 3
Glaucoma Multiple Logistic Regression Results Using the Modeling Set
Glaucoma group Parameter Estimate P-Value
All Intercept (β0) 18.29 <0.0001
GDx-TSNIT (β1) −0.41 <0.0001
NAP-FDT (β2) −1.18 0.0012
GDx-TSNIT*NAP-FDT (β3) 0.03 0.0001
Early Intercept (β0) 18.67 0.0001
GDx-TSNIT (β1) −0.42 <0.0001
NAP-FDT (β2) −1.80 0.0006
GDx-TSNIT*NAP-FDT (β3) 0.05 0.0002
Moderate Intercept (β0) 16.49 0.0045
GDx-TSNIT (β1) −0.42 0.0015
NAP-FDT (β2) −1.00 0.0627
GDx-TSNIT*NAP-FDT (β3) 0.03 0.0233
Severe Intercept (β0) 14.85 0.0448
GDx-TSNIT (β1) −0.40 0.0174
NAP-FDT (β2) −0.89 0.1200
GDx-TSNT*NADP-FDT (β3) 0.03 0.0360
TSNIT, average RNFL; NAP-FDT, number of abnormal points on FDT
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